Home

Jessica Hopfield

CIK 1648715 · last filed 2026-06-22

Jessica Hopfield is a corporate insider who has filed 48 SEC Form 4 insider transactions across 6 companies since 2015. The most recent filing, for EDIT, was dated Jun 22, 2026. Across all open-market trades the lifetime net is −$70.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.01M

Companies

6

Total Filings

48

Lifetime Open-Market Net

-$70.6K

Filer Profile

Reported Address
C/O INSULET CORPORATION
100 NAGOG PARK
ACTON, MA 01720
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EDIT Director 67,700 $3.23 $218.7K $1.01M 13 2026-06-22
PODD Director 29,355 $147.48 $4.33M -$3.18M 16 2026-05-21
MRVI Director 199,907 $7.32 $1.46M $1.35M 6 2025-06-18
Bruker Cellular Analysis, Inc. (CELL) Delisted Director 105,207 $1.00 $105.0K $0 2 2023-10-03
Bruker Cellular Analysis, Inc. (BLI) Delisted Director 109,237 $1.20 $131.1K $502.4K 4 2022-08-01
Radius Health, Inc. (RDUS) Delisted Director 18,300 $30.00 $549.0K $246.2K 3 2020-02-24

Recent Filings

48 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-22 EDIT Grant (A) — $0 EDGAR
2026-05-21 PODD Grant (A) +1,660 $0 EDGAR
2025-12-19 MRVI Notice (144) −53,951 -$187.5K EDGAR
2025-06-18 MRVI Grant (A) +89,139 $192.5K EDGAR
2025-06-10 EDIT Grant (A) — $0 EDGAR
2025-05-27 PODD Grant (A) +778 $0 EDGAR
2025-05-19 COR Notice (144) −12,185 -$3.57M EDGAR
2025-05-14 PODD Mixed — -$1.51M EDGAR
2025-05-13 PODD Notice (144) −5,235 -$1.66M EDGAR
2024-09-12 PODD Mixed — -$1.49M EDGAR
Showing 1–10 of 48
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.